A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...

A review and meta-analysis finds shorter antibiotic courses show similar efficacy for bloodstream infections in ...

Aging and neurodegeneration are both known to disrupt the production of functional proteins in cells—a process called ...

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...

As of March 31, Moderna had $5.97 billion in cash and short-term investments, with total debt of $745 million. But the company has been burning through cash quickly. Cash and short-term investments ...

White House Press Secretary Karoline Leavitt said on Thursday that President Donald Trump is set to send out letters to 17 ...

The discovery that brain ageing may be driven by jammed-up protein factories could lead to better ways to help us stay sharp ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

The company last reported total revenues of $108M in Q1, down 35.3% Y/Y due to lower net product sales, particularly its ...

Some good news, some ‘sobering,’ this month for tricuspid valve interventions, physician payments, and colchicine.

Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the end of the year as part of its effort to cut costs. In a statement on ...

Moderna is downsizing its workforce by 10% globally to bring headcount to under 5,000 in “a difficult moment for the company, ...